Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 321

GI Dynamics Welcomes New Members to Its Scientific Advisory Board

Posted by fidest press agency su giovedì, 17 agosto 2017

london-centralLondon. GI Dynamics® Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity, welcomed new members to the GI Dynamics Scientific Advisory Board (SAB), bringing together distinguished physicians and scientists specializing in endocrinology, gastroenterology and bariatric/metabolic surgery. Gerald Holtmann, MD, and Thomas Rösch, MD, have joined the GI Dynamics SAB. The GI Dynamics SAB was designed to advance the body of evidence and state of patient care through EndoBarrier utilization. The SAB will serve as a key resource to GI Dynamics during its Investigational Device Exemption clinical trial in the United States and will support ongoing clinical studies and commercialization in the United Kingdom, Germany, the Middle East and select European countries. “We are honored to have Dr. Holtmann and Dr. Rösch join the GI Dynamics SAB,” said Scott Schorer, president and chief executive officer of GI Dynamics. “Dr. Holtmann has developed a rich experience with EndoBarrier, and is currently the primary investigator of the ‘Effects and Mechanisms of Action of an Endoscopically Placed Duodenal-Jejunal Sleeve Device (EndoBarrier) in Obese Patients with Type 2 Diabetes: Focus on Intraluminal Triglyceride Digestion’ in Brisbane, Australia. Dr. Rösch has extensive gastroenterology and endoscopy experience; he conducted the first EndoBarrier procedures in Germany, and is leading the refinement of understanding mechanisms of action and the improvement of gastroenterological treatment protocols.” Dr. Holtmann is associate dean clinical at The University of Queensland and director of gastroenterology and hepatology at the Princess Alexandra Hospital in Brisbane. He also serves as director on boards of the West Moreton Hospital and Health Service and the Gallipoli Foundation.In addition to Dr. Holtmann’s training in medicine and gastroenterology, he completed a Master of Business Administration degree at the University of South Australia and is certified by the German Board of Physicians in Medical Informatics and Biostatistics. He has published more than 300 articles and book chapters in leading journals including the New England Journal of Medicine, Lancet, Gut and Gastroenterology, and has garnered more than 16,000 citations.In May 2016, Dr. Holtmann presented a poster on ‘Endoscopic Treatment of Obesity with a Duodenal-Jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss?’ at Digestive Disease Week (DDW). He also presented a poster on ‘Improvements of Liver and Glycemic Parameters After Duodenal-Jejunal Bypass Sleeve (DJBS) Insertion’ at DDW. “With my current research focused on the role of gut microbiome and brain–gut interactions, I’m excited to contribute to the GI Dynamics SAB,” said Dr. Holtmann. “Understanding the role of EndoBarrier should produce interesting research that will hopefully help patients.” Dr. Rösch is director of the Department of Interdisciplinary Endoscopy at the University Hospital Eppendorf in Hamburg, Germany. He previously was the chief of endoscopy and professor of diagnostic and therapeutic endoscopy at Charité Berlin, Campus Virchow Hospital from 2004 to 2008.Dr. Rösch has performed experimental studies on the topic of the secretion of pancreatic enzymes and has conducted scientific activity with endoscopy and endosonography in gastrointestinal diagnostics. His gastrointestinal research has been featured in over 230 publications, numerous review articles and more than 1,500 lectures. Dr. Rösch is also the editor of two endoscopic ultrasonography books and was editor in chief of the Endoscopy journal from 2004 to 2013, as well as deputy editor of endoscopy for the Gut journal. He is a board member of the German Society of Gastroenterology (DGVS) and of the DGVS Endoscopic Section. Dr. Rösch’s most recent study, ‘Performance Measures for Lower Gastrointestinal Endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative,’ is a multi-center approach by the ESGE and United European Gastroenterology. The study presented a list of key performance measures for lower gastrointestinal endoscopy to be adopted by pan-European endoscopy services.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: